Skip to main content

Table 1 Demographic characteristics of study participants

From: Assessing the impact of multidrug-resistant tuberculosis in children: an exploratory qualitative study

Participant age & identifier* Sex Ethnicity HIV status Duration of hospital admission
Younger children (age 5-10 years at start of MDR-TB treatment)
7a F Black Negative 3 months, 6 days
7b F Black Positive NA
8 F Coloured Negative 5 months, 21 days
9a F Black Positive 7 months, 5 days
9b F Coloured Negative NA
10 F Black Positive 5 months, 9 days
11a F Coloured Negative NA
11b F Black Negative 5 months, 7 days
11c F Coloured Positive 13 months, 4 days
11d F Coloured Negative 4 months, 1 day
11e F Black Negative 4 months
12 F Coloured Negative 3 months, 18 days
Older children (age ≥10 years at start of MDR-TB treatment)
14a M Black Positive 3 months, 24 days
14b M Black Negative 6 months, 28 days
15a M Black Positive 19 months, 25 days
15b M Black Positive 4 months, 27 days
15c M Coloured Negative 2 months
17a F Coloured Positive 8 months, 3 days
17b F Coloured Negative 1 month, 18 days
17c M Black Positive 1 month, 28 days
  1. Abbreviations: F Female, HIV Human immunodeficiency virus, M Male, MDR Multidrug-resistant tuberculosis, NA Not admitted, received outpatient treatment.
  2. *Unique identifiers were assigned to all participants. For example: “7a” refers to Child age 7, participant “a.” Ages are reported at the time of interview.
  3. †Self-reported: admission/discharge dates unavailable.